MedTech Dive January 23, 2024
J&J, Medtronic and Smith & Nephew executives and orthopedic surgeons said they expect more procedures to move outpatient, while questions about pricing and procedure backlogs loom over the space.
Orthopedics companies are preparing for a return to normal after a few tumultuous years influenced by the COVID-19 pandemic.
Last year, the medtech industry benefited from a “huge backlog of patients and pent-up demand, particularly for knee and hip replacements,” said Ryan Zimmerman, an analyst with BTIG. The year also brought big spine mergers, including the $3.1 billion tie-up between Globus Medical and Nuvasive, as well as planned spinoffs in the sector.
Going into 2024, orthopedics companies face questions about whether they expect the procedure backlog to continue, how...
Today's Sponsors
Today's Sponsor